July 2018 Issue

GO TO FULL ISSUE

Med Updates

Andexxa
inactivated recombinant factor Xa
Reversal agent for the factor Xa inhibitors apixaban and rivaroxaban.

Xhance
fluticasone propionate
New nasal steroid spray for nasal polyps.

Lonhala Magnair
glycopyrrolate
New oral inhalation solution formulation for COPD.

OTHER MED UPDATES